[PHARMA] QoQ TTM Result on 31-Dec-2012 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -24.36%
YoY- 18.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 1,861,183 1,846,836 1,865,940 1,812,346 1,697,728 1,642,700 1,582,398 11.41%
PBT 64,238 79,270 97,283 103,314 115,434 102,587 94,349 -22.58%
Tax -36,212 -29,878 -37,985 -40,108 -32,578 -34,308 -28,102 18.39%
NP 28,026 49,392 59,298 63,206 82,856 68,279 66,247 -43.61%
-
NP to SH 26,453 47,949 57,797 61,711 81,587 67,151 65,358 -45.25%
-
Tax Rate 56.37% 37.69% 39.05% 38.82% 28.22% 33.44% 29.79% -
Total Cost 1,833,157 1,797,444 1,806,642 1,749,140 1,614,872 1,574,421 1,516,151 13.48%
-
Net Worth 473,402 480,568 484,829 472,037 496,469 481,394 474,161 -0.10%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div 37,168 41,172 41,189 41,188 64,713 52,948 44,120 -10.79%
Div Payout % 140.51% 85.87% 71.27% 66.74% 79.32% 78.85% 67.51% -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 473,402 480,568 484,829 472,037 496,469 481,394 474,161 -0.10%
NOSH 258,689 258,370 117,676 117,715 117,646 117,700 117,657 69.00%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 1.51% 2.67% 3.18% 3.49% 4.88% 4.16% 4.19% -
ROE 5.59% 9.98% 11.92% 13.07% 16.43% 13.95% 13.78% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 719.47 714.80 1,585.65 1,539.60 1,443.07 1,395.66 1,344.91 -34.07%
EPS 10.23 18.56 49.11 52.42 69.35 57.05 55.55 -67.59%
DPS 14.37 15.94 35.00 35.00 55.00 44.99 37.50 -47.21%
NAPS 1.83 1.86 4.12 4.01 4.22 4.09 4.03 -40.89%
Adjusted Per Share Value based on latest NOSH - 117,715
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 129.14 128.14 129.47 125.75 117.80 113.98 109.80 11.41%
EPS 1.84 3.33 4.01 4.28 5.66 4.66 4.53 -45.12%
DPS 2.58 2.86 2.86 2.86 4.49 3.67 3.06 -10.74%
NAPS 0.3285 0.3334 0.3364 0.3275 0.3445 0.334 0.329 -0.10%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 4.82 4.49 8.26 8.10 7.55 10.18 5.90 -
P/RPS 0.67 0.63 0.52 0.53 0.52 0.73 0.44 32.32%
P/EPS 47.14 24.19 16.82 15.45 10.89 17.84 10.62 169.84%
EY 2.12 4.13 5.95 6.47 9.19 5.60 9.42 -62.96%
DY 2.98 3.55 4.24 4.32 7.28 4.42 6.36 -39.64%
P/NAPS 2.63 2.41 2.00 2.02 1.79 2.49 1.46 47.99%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 -
Price 4.72 4.66 9.26 7.80 8.25 8.83 5.90 -
P/RPS 0.66 0.65 0.58 0.51 0.57 0.63 0.44 31.00%
P/EPS 46.16 25.11 18.85 14.88 11.90 15.48 10.62 166.09%
EY 2.17 3.98 5.30 6.72 8.41 6.46 9.42 -62.38%
DY 3.04 3.42 3.78 4.49 6.67 5.09 6.36 -38.83%
P/NAPS 2.58 2.51 2.25 1.95 1.95 2.16 1.46 46.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment